Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

NCT ID: NCT02681458

Last Updated: 2016-05-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1436 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-08-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There were two groups with overall members of 1436. Statistically, the investigators have used "Likelihood ratio " and " Exact's Fisher" tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin and Subcutaneous Tissue Fungal Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drug Users

Case group that consisted of drug users with fungal infections

Direct Examination

Intervention Type OTHER

It was an observational study and subjects received their routine treatment.

Non-drug Users

Control group that consisted of non drug users with fungal infections

Direct Examination

Intervention Type OTHER

It was an observational study and subjects received their routine treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Direct Examination

It was an observational study and subjects received their routine treatment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suspected fungal lesions

Exclusion Criteria

* non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Islamic Azad University of Mashhad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hassan Yazdanfar

Head of parasitology and mycology department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hassan Yazdanfar, MD, PhD

Role: STUDY_CHAIR

assistant professor of mycology and parasitology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Islamic Azad University of Mashhad

Mashhad, Khorasan Razavi, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IslamicAUM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Pharmacokinetics of Rezafungin
NCT04117607 TERMINATED PHASE1